Cargando…
Overcoming regulatory gaps in biological materials oversight by enhancing IBC protocol review
In the United States, several regulations and federal policies govern the use of potentially biohazardous materials in research and industry. Part of this oversight is assigned by mandate to Institutional Biosafety Committees (IBCs). However, most research entities give additional responsibilities t...
Autores principales: | Rainer, David, Cook, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149535/ http://dx.doi.org/10.1016/B978-0-12-801885-9.00005-6 |
Ejemplares similares
-
US federal oversight of biological materials and the IBC
por: Howard, Deborah
Publicado: (2016) -
Innovation in biosafety oversight: The Harvard Catalyst Common Reciprocal IBC Reliance Authorization Agreement
por: Caruso, Rebecca, et al.
Publicado: (2020) -
Regulatory Oversight and Safety of Probiotic Use
por: Venugopalan, Veena, et al.
Publicado: (2010) -
Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium
por: Devi, Gayathri R., et al.
Publicado: (2019) -
Select agent program impact on the IBC
por: Adamovicz, Jeffery
Publicado: (2016)